Literature DB >> 17163414

Role of glycolysis inhibition and poly(ADP-ribose) polymerase activation in necrotic-like cell death caused by ascorbate/menadione-induced oxidative stress in K562 human chronic myelogenous leukemic cells.

Julien Verrax1, Stéphanie Vanbever, Julie Stockis, Henryk Taper, Pedro Buc Calderon.   

Abstract

Among different features of cancer cells, two of them have retained our interest: their nearly universal glycolytic phenotype and their sensitivity towards an oxidative stress. Therefore, we took advantage of these features to develop an experimental approach by selectively exposing cancer cells to an oxidant insult induced by the combination of menadione (vitamin K(3)) and ascorbate (vitamin C). Ascorbate enhances the menadione redox cycling, increases the formation of reactive oxygen species and kills K562 cells as shown by more than 65% of LDH leakage after 24 hr of incubation. Since both lactate formation and ATP content are depressed by about 80% following ascorbate/menadione exposure, we suggest that the major intracellular event involved in such a cytotoxicity is related to the impairment of glycolysis. Indeed, NAD(+) is rapidly and severely depleted, a fact most probably related to a strong Poly(ADP-ribose) polymerase (PARP) activation, as shown by the high amount of poly-ADP-ribosylated proteins. The addition of N-acetylcysteine (NAC) restores most of the ATP content and the production of lactate as well. The PARP inhibitor dihydroxyisoquinoline (DiQ) was able to partially restore both parameters as well as cell death induced by ascorbate/menadione. These results suggest that the PARP activation induced by the oxidative stress is a major but not the only intracellular event involved in cell death by ascorbate/menadione. Due to the high energetic dependence of cancer cells on glycolysis, the impairment of such an essential pathway may explain the effectiveness of this combination to kill cancer cells. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163414     DOI: 10.1002/ijc.22439

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study.

Authors:  Raphaël Beck; Rozangela Curi Pedrosa; Nicolas Dejeans; Christophe Glorieux; Philippe Levêque; Bernard Gallez; Henryk Taper; Stéphane Eeckhoudt; Laurent Knoops; Pedro Buc Calderon; Julien Verrax
Journal:  Invest New Drugs       Date:  2010-05-08       Impact factor: 3.850

Review 2.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

3.  NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death.

Authors:  Conrad C Alano; Philippe Garnier; Weihai Ying; Youichirou Higashi; Tiina M Kauppinen; Raymond A Swanson
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

Review 4.  Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.

Authors:  Sascha Venturelli; Tobias W Sinnberg; Heike Niessner; Christian Busch
Journal:  Wien Med Wochenschr       Date:  2015-06-12

Review 5.  Mitochondrial dysfunction induced by nuclear poly(ADP-ribose) polymerase-1: a treatable cause of cell death in stroke.

Authors:  Paul Baxter; Yanting Chen; Yun Xu; Raymond A Swanson
Journal:  Transl Stroke Res       Date:  2013-09-07       Impact factor: 6.829

6.  Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.

Authors:  Peter Bober; Michal Alexovic; Ivan Talian; Zuzana Tomkova; Zuzana Viscorova; Maria Benckova; Igor Andrasina; Rachele Ciccocioppo; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak; Jan Sabo
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

7.  Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry.

Authors:  Maxim Isabelle; Xavier Moreel; Jean-Philippe Gagné; Michèle Rouleau; Chantal Ethier; Pierre Gagné; Michael J Hendzel; Guy G Poirier
Journal:  Proteome Sci       Date:  2010-04-13       Impact factor: 2.480

8.  Vitamin C in synergism with cisplatin induces cell death in cervical cancer cells through altered redox cycling and p53 upregulation.

Authors:  Ankita Leekha; Bahadur S Gurjar; Aakriti Tyagi; Moshahid A Rizvi; Anita K Verma
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-09       Impact factor: 4.553

9.  Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract.

Authors:  Christoph Otto; Theresa Hahlbrock; Kilian Eich; Ferdi Karaaslan; Constantin Jürgens; Christoph-Thomas Germer; Armin Wiegering; Ulrike Kämmerer
Journal:  BMC Complement Altern Med       Date:  2016-06-01       Impact factor: 3.659

10.  Catalase down-regulation in cancer cells exposed to arsenic trioxide is involved in their increased sensitivity to a pro-oxidant treatment.

Authors:  Christophe Glorieux; Pedro Buc Calderon
Journal:  Cancer Cell Int       Date:  2018-02-20       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.